221
Views
81
CrossRef citations to date
0
Altmetric
Original Articles

Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol

, , , , &
Pages 1883-1887 | Received 06 Feb 2003, Accepted 16 May 2003, Published online: 22 May 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Siukan Law, Albert Wingnang Leung & Chuanshan Xu. (2020) Folic acid-modified celastrol nanoparticles: synthesis, characterization, anticancer activity in 2D and 3D breast cancer models. Artificial Cells, Nanomedicine, and Biotechnology 48:1, pages 542-559.
Read now
Zhanrong Li, Xianghua Wu, Jingguo Li, Lin Yao, Limei Sun, Yingying Shi, Wenxin Zhang, Jianxian Lin, Dan Liang & Yongping Li. (2012) Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model. International Journal of Nanomedicine 7, pages 2389-2398.
Read now
Min Huang, Jin-Jian Lu, Ming-Qing Huang, Jiao-Lin Bao, Xiu-Ping Chen & Yi-Tao Wang. (2012) Terpenoids: natural products for cancer therapy. Expert Opinion on Investigational Drugs 21:12, pages 1801-1818.
Read now
Xin Huang, Min Yang & Jie Jin. (2012) Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs. Leukemia & Lymphoma 53:6, pages 1188-1195.
Read now
Pengfei Ge, Xunming Ji, Yuchuan Ding, Xiaofei Wang, Shuangliin Fu, Fankai Meng, Xin Jin, Feng Ling & Yinan Luo. (2010) Celastrol causes apoptosis and cell cycle arrest in rat glioma cells. Neurological Research 32:1, pages 94-100.
Read now
Hong Zhu, Wan-Jing Ding, Rui Wu, Qin-Jie Weng, Jian-Shu Lou, Rong-Jia Jin, Wei Lu, Bo Yang & Qiao-Jun He. (2010) Synergistic Anti-Cancer Activity by the Combination of TRAIL/APO-2L and Celastrol. Cancer Investigation 28:1, pages 23-32.
Read now
Suzanna E. L. Temple & Grant W. Waterer. (2006) Role of heat-shock protein 70 in multiple-organ dysfunction syndrome. Journal of Organ Dysfunction 2:2, pages 101-115.
Read now

Articles from other publishers (74)

Shuhan Jin, Bo Li, Bibo Zhang, Xuejie Gao, Xinyan Jia, Li Xu, Shuaikang Chang, Ke Hu, Guanli Wang, Zhijian Xu, Ting Zhang, Dongliang Song, Guang Yang, Xiaosong Wu, Huabin Zhu, Cheng Huang, Yumeng Lu, Jumei Shi, Weiliang Zhu & Gege Chen. (2023) Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation. Acta Biochimica et Biophysica Sinica.
Crossref
Mohamed O. Radwan, Howaida I. Abd-Alla, Azhaar T. Alsaggaf, Hatem El-Mezayen, Mohammed A. S. Abourehab, Mohamed E. El-Beeh, Hiroshi Tateishi, Masami Otsuka & Mikako Fujita. (2023) Gypsogenin Battling for a Front Position in the Pentacyclic Triterpenes Game of Thrones on Anti-Cancer Therapy: A Critical Review—Dedicated to the Memory of Professor Hanaa M. Rady. Molecules 28:15, pages 5677.
Crossref
Yao Feng, Wenbao Wang, Yan Zhang, Xuefeng Fu, Kunqi Ping, Jiaxing Zhao, Yu Lei, Yanhua Mou & Shaojie Wang. (2022) Synthesis and biological evaluation of celastrol derivatives as potential anti-glioma agents by activating RIP1/RIP3/MLKL pathway to induce necroptosis. European Journal of Medicinal Chemistry 229, pages 114070.
Crossref
Samarpita Banerjee, Champa Keeya Tudu, Samapika Nandy, Devendra K. Pandey, Mimosa Ghorai, Mahipal S. Shekhawat, Arabinda Ghosh, Potshangbam Nongdam, Abdel R. Al-Tawaha, Ercan Bursal, Gaber E-S Batiha, Suchhanda Ghosh, Vinay Kumar & Abhijit Dey. 2022. Herbal Medicines. Herbal Medicines 37 69 .
Daniel Sol Sol de Medeiros, Simone Tasca Cargnin, Ana Paula Azevedo dos Santos, Moreno de Souza Rodrigues, Fernando Berton Zanchi, Patrícia Soares de Maria de Medeiros, Alexandre de Almeida e Silva, Carolina Bioni Garcia Teles & Simone Cristina Baggio Gnoatto. (2021) Ursolic and betulinic semisynthetic derivatives show activity against CQ‐resistant Plasmodium falciparum isolated from Amazonia . Chemical Biology & Drug Design 97:5, pages 1038-1047.
Crossref
Nayely Padilla-Montaño, Leandro de León Guerra & Laila Moujir. (2021) Antimicrobial Activity and Mode of Action of Celastrol, a Nortriterpen Quinone Isolated from Natural Sources. Foods 10:3, pages 591.
Crossref
Arvind Singh Negi. 2021. Discovery and Development of Anti-Breast Cancer Agents from Natural Products. Discovery and Development of Anti-Breast Cancer Agents from Natural Products 29 68 .
Luis Apaza Ticona, María Rodríguez Coballes, Giulia Potente & Ángel Rumbero Sánchez. (2020) Anti-inflammatory Potential of Macamides Isolated from Yellow Tubers of Mashua (Tropaeolum Tuberosum). Planta Medica International Open 07:03, pages e88-e99.
Crossref
Elaine C. D. Gonçalves, Gabriela M. Baldasso, Maíra A. Bicca, Rodrigo S. Paes, Raffaele Capasso & Rafael C. Dutra. (2020) Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant. Molecules 25:7, pages 1567.
Crossref
Wei Hou, Bo Liu & Hongtao Xu. (2020) Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology. European Journal of Medicinal Chemistry 189, pages 112081.
Crossref
Minjian Chen, Jing Yang, Lei Li, Yanhui Hu, Xiaomei Lu, Rongli Sun, Yubang Wang, Xinru Wang & Xiaoling Zhang. (2020) Metabolomics Reveals that Cysteine Metabolism Plays a Role in Celastrol-Induced Mitochondrial Apoptosis in HL-60 and NB-4 Cells. Scientific Reports 10:1.
Crossref
Bin Peng, Ying Wang, Yu-Ting Song, Xue Zhang, Fan-Fan Cao, Li-Min Xu, Mei Jiang, Xiao-Ling Bo, Georges Uzan & Deng-Hai Zhang. 2019. Heat Shock Protein 90 in Human Diseases and Disorders. Heat Shock Protein 90 in Human Diseases and Disorders 441 470 .
Huang Xiao-pei, Chen Ji-kuai, Wei Xue, Yi-Fan Dong, Lang Yan, Zhang Xiao-fang, Pan Ya-min, Chang Wen-jun & Zhu Jiang-bo. (2018) Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol. Bioscience Reports 38:6.
Crossref
Uddin Nazim, Honghua Yin & Sang‑Youel Park. (2018) Autophagy flux inhibition mediated by celastrol sensitized lung cancer cells to TRAIL‑induced apoptosis via regulation of mitochondrial transmembrane potential and reactive oxygen species. Molecular Medicine Reports.
Crossref
Zar Chi Soe, Raj Kumar Thapa, Wenquan Ou, Milan Gautam, Hanh Thuy Nguyen, Sung Giu Jin, Sae Kwang Ku, Kyung Taek Oh, Han-Gon Choi, Chul Soon Yong & Jong Oh Kim. (2018) Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy. Colloids and Surfaces B: Biointerfaces 170, pages 718-728.
Crossref
Dharambir Kashyap, Ajay Sharma, Hardeep Singh Tuli, Katrin Sak, Tapan Mukherjee & Anupam Bishayee. (2018) Molecular targets of celastrol in cancer: Recent trends and advancements. Critical Reviews in Oncology/Hematology 128, pages 70-81.
Crossref
Nur S. Amirruddin, Alan P. Kumar, Adrian K.K. Teo & Gautam Sethi. 2018. Role of Nutraceuticals in Chemoresistance to Cancer. Role of Nutraceuticals in Chemoresistance to Cancer 141 150 .
Noah Dukler, Gregory T. Booth, Yi-Fei Huang, Nathaniel Tippens, Colin T. Waters, Charles G. Danko, John T. Lis & Adam Siepel. (2017) Nascent RNA sequencing reveals a dynamic global transcriptional response at genes and enhancers to the natural medicinal compound celastrol. Genome Research 27:11, pages 1816-1829.
Crossref
Wei-Guang Shan, Han-Guang Wang, Yan Chen, Rui Wu, Yan-Tao Wen, Li-Wen Zhang, You-Min Ying, Jian-Wei Wang & Zha-Jun Zhan. (2017) Synthesis of 3- and 29-substituted celastrol derivatives and structure-activity relationship studies of their cytotoxic activities. Bioorganic & Medicinal Chemistry Letters 27:15, pages 3450-3453.
Crossref
Rita Cascão, João E. Fonseca & Luis F. Moita. (2017) Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases. Frontiers in Medicine 4.
Crossref
Yan-Yan Yan, Fang Wang, Xiao-Qin Zhao, Xiao-Kun Wang, Yi-Fan Chen, Hong Liu, Yong Xie & Li-Wu Fu. (2017) Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro. Oncology Reports 37:1, pages 31-40.
Crossref
Stephen Safe & Ravi Kasiappan. (2016) Natural Products as Mechanism-based Anticancer Agents: Sp Transcription Factors as Targets. Phytotherapy Research 30:11, pages 1723-1732.
Crossref
Xiaoling Zhang, Jing Yang, Minjian Chen, Lei Li, Fei Huan, Aiping Li, Yanqing Liu, Yankai Xia, Jin-ao Duan & Shiping Ma. (2016) Metabolomics profiles delineate uridine deficiency contributes to mitochondria-mediated apoptosis induced by celastrol in human acute promyelocytic leukemia cells. Oncotarget 7:29, pages 46557-46572.
Crossref
Gaurav Garg, Anuj Khandelwal & Brian S.J. Blagg. 2016. Hsp90 in Cancer: Beyond the Usual Suspects. Hsp90 in Cancer: Beyond the Usual Suspects 51 88 .
Fabianne Lacouth-Silva, Caroline V. Xavier, Sulamita da S. Setúbal, Adriana S. Pontes, Neriane M. Nery, Onassis Boeri de Castro, Carla F. C. Fernandes, Eduardo R. Honda, Fernando B. Zanchi, Leonardo A. Calderon, Rodrigo G. Stábeli, Andreimar M. Soares, Izaltina Silva-Jardim, Valdir A. Facundo & Juliana P. Zuliani. (2015) The effect of 3β, 6β, 16β-trihydroxylup-20(29)-ene lupane compound isolated from Combretum leprosum Mart. on peripheral blood mononuclear cells. BMC Complementary and Alternative Medicine 15:1.
Crossref
Erik Niemelä, Diti Desai, Yves Nkizinkiko, John E. Eriksson & Jessica M. Rosenholm. (2015) Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells. European Journal of Pharmaceutics and Biopharmaceutics 96, pages 11-21.
Crossref
Sebastian AltenhöferKim A. RadermacherPamela W.M. KleikersKirstin WinglerHarald H.H.W. Schmidt. (2015) Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement. Antioxidants & Redox Signaling 23:5, pages 406-427.
Crossref
Shweta Shrivastava, Manish Kumar Jeengar, V. Sudhakar Reddy, G. Bhanuprakash Reddy & V.G.M. Naidu. (2015) Anticancer effect of celastrol on human triple negative breast cancer: Possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways. Experimental and Molecular Pathology 98:3, pages 313-327.
Crossref
Gurpreet Kaur & Neelam Verma. (2015) Nature curing cancer – review on structural modification studies with natural active compounds having anti-tumor efficiency. Biotechnology Reports 6, pages 64-78.
Crossref
Marco Lo Iacono, Valentina Monica, Tiziana Vavalà, Mara Gisabella, Silvia Saviozzi, Enrico Bracco, Silvia Novello, Mauro Papotti & Giorgio Vittorio Scagliotti. (2015) ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway. International Journal of Cancer 136:11, pages 2598-2609.
Crossref
Pei-Pei Li, Wei He, Ping-Fan Yuan, Sha-Sha Song, Jing-Tao Lu & Wei Wei. (2015) Celastrol Induces Mitochondria-Mediated Apoptosis in Hepatocellular Carcinoma Bel-7402 Cells. The American Journal of Chinese Medicine 43:01, pages 137-148.
Crossref
Li Lu, Wenli Shi, Rahul R. Deshmukh, Jie Long, Xiaoli Cheng, Weidong Ji, Guohua Zeng, Xianliang Chen, Yajie Zhang & Q. Ping Dou. (2014) Tumor Necrosis Factor-α Sensitizes Breast Cancer Cells to Natural Products with Proteasome-Inhibitory Activity Leading to Apoptosis. PLoS ONE 9:11, pages e113783.
Crossref
JingYuan Li, LiXin Shi, YiXiang Shao, Matthias Selke, BaoAn Chen, Hui Jiang & XueMei Wang. (2014) The cellular labeling and pH-sensitive responsive-drug release of celastrol in cancer cells based on Cys-CdTe QDs. Science China Chemistry 57:6, pages 833-841.
Crossref
Haiwen Ni, Wanzhou Zhao, Xiangtu Kong, Haitao Li & Jian Ouyang. (2014) NF-Kappa B Modulation Is Involved in Celastrol Induced Human Multiple Myeloma Cell Apoptosis. PLoS ONE 9:4, pages e95846.
Crossref
Chunzhang Yang, Cody L. Swallows, Chao Zhang, Jie Lu, Hongbin Xiao, Roscoe O. Brady & Zhengping Zhuang. (2013) Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones. Proceedings of the National Academy of Sciences 111:1, pages 249-254.
Crossref
Bernadett Kalmar, Ching-Hua Lu & Linda Greensmith. (2014) The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol. Pharmacology & Therapeutics 141:1, pages 40-54.
Crossref
Chaitanya A. Patwardhan, Abdul Fauq, Laura B. Peterson, Charles Miller, Brian S.J. Blagg & Ahmed Chadli. (2013) Gedunin Inactivates the Co-chaperone p23 Protein Causing Cancer Cell Death by Apoptosis. Journal of Biological Chemistry 288:10, pages 7313-7325.
Crossref
YAN-YAN YAN, JIAN-PING BAI, YONG XIE, JIE-ZHONG YU & CUN-GEN MA. (2013) The triterpenoid pristimerin induces U87 glioma cell apoptosis through reactive oxygen species-mediated mitochondrial dysfunction. Oncology Letters 5:1, pages 242-248.
Crossref
Ju-Hye Lee, Yeong-Seon Won, Ki-Hun Park, Mi-Kyung Lee, Hirofumi Tachibana, Koji Yamada & Kwon-Il Seo. (2012) Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling. Apoptosis 17:12, pages 1275-1286.
Crossref
Wenzong Lu, Guangfeng Jia, Xiangyan Meng, Chen Zhao, Liang Zhang, Yumiao Ren, Haixian Pan & Yuan Ni. (2012) Beta-catenin mediates the apoptosis induction effect of celastrol in HT29 cells. Life Sciences 91:7-8, pages 279-283.
Crossref
Muthu K. Shanmugam, An H. Nguyen, Alan P. Kumar, Benny K.H. Tan & Gautam Sethi. (2012) Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer. Cancer Letters 320:2, pages 158-170.
Crossref
Wen-Bo Wang, Li-Xing Feng, Qing-Xi Yue, Wan-Ying Wu, Shu-Hong Guan, Bao-Hong Jiang, Min Yang, Xuan Liu & De-An Guo. (2012) Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90. Journal of Cellular Physiology 227:5, pages 2196-2206.
Crossref
Gayathri Chadalapaka, Indira Jutooru & Stephen Safe. (2012) Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells. Carcinogenesis 33:4, pages 886-894.
Crossref
Jing Liu, Yi Hu, David L. Waller, Junfeng Wang & Qingsong Liu. (2012) Natural products as kinase inhibitors. Natural Product Reports 29:3, pages 392.
Crossref
Min Li-Weber. 2012. Materia Medica for Various Cancers. Materia Medica for Various Cancers 229 259 .
Guozhu Chen, Xuhui Zhang, Ming Zhao, Yan Wang, Xiang Cheng, Di Wang, Yuanji Xu, Zhiyan Du & Xiaodan Yu. (2011) Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells. BMC Cancer 11:1.
Crossref
Lin-Li Zhou, Zhi-Xiu Lin, Kwok-Pui Fung, Christopher H.K. Cheng, Chun-Tao Che, Ming Zhao, Shi-Hua Wu & Zhong Zuo. (2011) Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-κB activity. European Journal of Pharmacology 670:2-3, pages 399-408.
Crossref
Radhamani Kannaiyan, Kanjoormana Aryan Manu, Luxi Chen, Feng Li, Peramaiyan Rajendran, Aruljothi Subramaniam, Paula Lam, Alan Prem Kumar & Gautam Sethi. (2011) Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways. Apoptosis 16:10, pages 1028-1041.
Crossref
Haibo Mou, Yi Zheng, Peng Zhao, Hanying Bao, Weijia Fang & Nong Xu. (2011) Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways. Toxicology in Vitro 25:5, pages 1027-1032.
Crossref
Haeng Ran Seo, Woo Duck Seo, Bo-Jeong Pyun, Byong Won Lee, Yeung Bae Jin, Ki Hun Park, Eun-Kyoung Seo, Yoon-Jin Lee & Yun-Sil Lee. (2011) Radiosensitization by celastrol is mediated by modification of antioxidant thiol molecules. Chemico-Biological Interactions 193:1, pages 34-42.
Crossref
Zi Liu, Liang Ma & Guang-Biao Zhou. (2011) The Main Anticancer Bullets of the Chinese Medicinal Herb, Thunder God Vine. Molecules 16:6, pages 5283-5297.
Crossref
Hee-Sun Yang, Jae-Yong Kim, Ju-Hye Lee, Byong-Won Lee, Ki-Hun Park, Ki-Hwan Shim, Mi-Kyung Lee & Kwon-Il Seo. (2011) Celastrol isolated from Tripterygium regelii induces apoptosis through both caspase-dependent and -independent pathways in human breast cancer cells. Food and Chemical Toxicology 49:2, pages 527-532.
Crossref
Yoonseo Kim, Hyereen Kang, Sung-Wuk Jang & Jesang Ko. (2011) Celastrol Inhibits Breast Cancer Cell Invasion via Suppression of NF-ĸB-mediated Matrix Metalloproteinase-9 Expression. Cellular Physiology and Biochemistry 28:2, pages 175-184.
Crossref
Jingyuan Li, Xuemei Wang, Hui Jiang, Xiaohua Lu, Yudan Zhu & Baoan Chen. (2011) New strategy of photodynamic treatment of TiO2 nanofibers combined with celastrol for HepG2 proliferation in vitro. Nanoscale 3:8, pages 3115.
Crossref
Soon Young Jang, Sung-Wuk Jang & Jesang Ko. (2011) Celastrol inhibits the growth of estrogen positive human breast cancer cells through modulation of estrogen receptor α. Cancer Letters 300:1, pages 57-65.
Crossref
Bin Peng, Limin Xu, Fanfan Cao, Tingxuan Wei, Chunxin Yang, Georges Uzan & Denghai Zhang. (2010) HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way. Molecular Cancer 9:1.
Crossref
Vivek R. Yadav, Bokyung Sung, Sahdeo Prasad, Ramaswamy Kannappan, Sung-Gook Cho, Mingyao Liu, Madan M. Chaturvedi & Bharat B. Aggarwal. (2010) Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor. Journal of Molecular Medicine 88:12, pages 1243-1253.
Crossref
Denghai Zhang, Limin Xu, Fanfan Cao, Tingxuan Wei, Chunxin Yang, Georges Uzan & Bin Peng. (2010) Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way. Cell Stress and Chaperones 15:6, pages 939-946.
Crossref
Antero Salminen, Marko Lehtonen, Tuomas Paimela & Kai Kaarniranta. (2010) Celastrol: Molecular targets of Thunder God Vine. Biochemical and Biophysical Research Communications 394:3, pages 439-442.
Crossref
Xiufeng Pang, Zhengfang Yi, Jing Zhang, Binbin Lu, Bokyung Sung, Weijing Qu, Bharat B. Aggarwal & Mingyao Liu. (2010) Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway. Cancer Research 70:5, pages 1951-1959.
Crossref
Ahmed Chadli, Sara J. Felts, Qin Wang, William P. Sullivan, Maria Victoria Botuyan, Abdul Fauq, Marina Ramirez-Alvarado & Georges Mer. (2010) Celastrol Inhibits Hsp90 Chaperoning of Steroid Receptors by Inducing Fibrillization of the Co-chaperone p23. Journal of Biological Chemistry 285:6, pages 4224-4231.
Crossref
Alessia Petronelli, Gaetano Pannitteri & Ugo Testa. (2009) Triterpenoids as new promising anticancer drugs. Anti-Cancer Drugs 20:10, pages 880-892.
Crossref
Joo-Yun Byun, Min-Jung Kim, Da-Young Eum, Chang-Hwan Yoon, Woo-Duck Seo, Ki Hun Park, Jin-Won Hyun, Yun-Sil Lee, Jae-Seong Lee, Moon-Young Yoon & Su-Jae Lee. (2009) Reactive Oxygen Species-Dependent Activation of Bax and Poly(ADP-ribose) Polymerase-1 Is Required for Mitochondrial Cell Death Induced by Triterpenoid Pristimerin in Human Cervical Cancer Cells. Molecular Pharmacology 76:4, pages 734-744.
Crossref
Thangaiyan Rabi & Anupam Bishayee. (2008) Terpenoids and breast cancer chemoprevention. Breast Cancer Research and Treatment 115:2, pages 223-239.
Crossref
Qibing Zhou. 2009. Quinone Methides. Quinone Methides 269 295 .
Bernadett Kalmar & Linda Greensmith. (2009) Activation of the heat shock response in a primary cellular model of motoneuron neurodegeneration-evidence for neuroprotective and neurotoxic effects. Cellular and Molecular Biology Letters 14:2.
Crossref
William N. Setzer. (2008) Non-Intercalative Triterpenoid Inhibitors of Topoisomerase II: A Molecular Docking Study. The Open Bioactive Compounds Journal 1, pages 13-17.
Crossref
Duane C. Hassane, Monica L. Guzman, Cheryl Corbett, Xiaojie Li, Ramzi Abboud, Fay Young, Jane L. Liesveld, Martin Carroll & Craig T. Jordan. (2008) Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. Blood 111:12, pages 5654-5662.
Crossref
Yulun Huang, Youxin Zhou, Yisun Fan & Dai Zhou. (2008) Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression. Cancer Letters 264:1, pages 101-106.
Crossref
Wenyan Wang, Ke Liu, Hongwei Dong & Wanhui Liu. (2008) High-performance liquid chromatography spectrometric analysis of tripterin in rat plasma. Journal of Chromatography B 863:1, pages 163-166.
Crossref
Gautam Sethi, Kwang Seok Ahn, Manoj K. Pandey & Bharat B. Aggarwal. (2006) Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-κB–regulated gene products and TAK1-mediated NF-κB activation. Blood 109:7, pages 2727-2735.
Crossref
Jon Holy, Genelle Lamont & Edward Perkins. (2006) Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine. BMC Cell Biology 7:1.
Crossref
Deng-hai Zhang, Anthony Marconi, Li-min Xu, Chun-xin Yang, Guo-wu Sun, Xiao-ling Feng, Chang-quan Ling, Wan-zhang Qin, Georges Uzan & Patrizia d’Alessio. (2006) Tripterine inhibits the expression of adhesion molecules in activated endothelial cells. Journal of Leukocyte Biology 80:2, pages 309-319.
Crossref
Huanjie Yang, Di Chen, Qiuzhi Cindy Cui, Xiao Yuan & Q. Ping Dou. (2006) Celastrol, a Triterpene Extracted from the Chinese “Thunder of God Vine,” Is a Potent Proteasome Inhibitor and Suppresses Human Prostate Cancer Growth in Nude Mice. Cancer Research 66:9, pages 4758-4765.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.